The spoilage of beer significantly threatens the quality and safety of products in the beverage industry. Certain natural foods contain beneficial bioactive components that are considered to be safer than chemical additives. This study aimed to identify extracts of natural foods as potential alternatives to chemical preservatives for controlling beer spoilage microorganisms. Among the two extraction methods applied to 176 natural foods, the extracts of clove alone effectively inhibited the growth of representative beer spoilage microorganisms, specifically Levilactobacillus brevis, Sporolactobacillus vineae, Pectinatus frisingensis, and Saccharomyces cerevisiae var. diastaticus. High-performance liquid chromatography and half-maximal inhibitory concentration analysis revealed that gallic acid and eugenol in cloves were active compounds with antimicrobial properties in vitro that were of a similar order of magnitude to those of commercial preservatives (potassium sorbate and sodium benzoate) under the tested conditions. Scanning electron microscopy observations and a fluorescence leakage assay using 3,3′-dipropylthiadicarbocyanine iodide indicated morphological alterations and membrane perturbation in treated microorganisms, except for the limited effect of gallic acid on S. cerevisiae var. diastaticus. These findings provide insight into the potential role of natural food-derived antimicrobials in controlling beer spoilage microorganisms, pending further validation in real beverage systems. 

Anaerobic digestion (AD) is a cornerstone technology for sustainable waste treatment and renewable energy recovery, yet its complex microbe–metabolite interactions remain poorly understood. Here, we combined high-resolution molecular profiling and microbial community sequencing in a three-month study across seven full-scale digesters to resolve dissolved organic matter (DOM) and microbiome dynamics. A total of 28 925 DOM molecules, including a conserved core of 1154 metabolites, were identified. By disentangling metabolic pathways, we observed complex transformation patterns that extend beyond simple substrate breakdown. Molecules within a mass window (183.57–390.81 m/z) exhibited high persistence, strong microbial associations, and distinct transformation trajectories. Within this mass window, microbial community composition and feedstock input, together explained ~30.1%–43.4% of the observed spatiotemporal variation. In each digester, 1260–2108 molecules were closely associated with microbial metabolism, forming 7.77–24.52 microbe–metabolite associations on average. The accumulation and turnover of these microbial metabolites were strongly linked to methane production and system performance, highlighting microbial processing of DOM as a significant factor shaping microbe–metabolite interactions. This perspective emphasizes the importance of microbe–metabolite interplay in AD, providing a conceptual framework for predictive monitoring and optimization of engineered biotechnologies.

Genome-editing technologies that use recombinases to insert kilobase-scale DNA sequences into mammalian genomes canonically require large double-stranded DNA (dsDNA) donors. However, dsDNA molecules evoke problematic and toxic innate immune responses, limiting integration efficiencies and generally constraining applicability to ex vivo or immune-deficient contexts. By harnessing mechanisms of integrative prokaryotic viruses and mobile genetic elements, here we demonstrate that recombinases are compatible with immune evasive circular single-stranded DNA molecules optimally bearing a partial-duplex region that reconstitutes the recombinase recognition sequence. This approach, which we term integration through nucleus-synthesized template addition of large lengths (INSTALL), is compatible with diverse protein and RNA-guided recombinases for high-fidelity kilobase-scale human genome writing. INSTALL minimizes innate immune responses in primary human cells and in mice, improving recombinase-mediated integration efficiencies and supporting systemic in vivo non-viral DNA delivery by substantially increasing tolerability and broadening the dosing range compared with lipid nanoparticle-delivered dsDNA molecules. Together, INSTALL overcomes fundamental challenges for DNA delivery and integration methods by synergizing immune-stealth nucleic acids with recombinases to enable kilobase-scale integration strategies without viral vectors. INSTALL overcomes fundamental challenges for DNA delivery and integration methods by synergizing immune-stealth nucleic acids with recombinases to enable kilobase-scale integration strategies without viral vectors.

Engineered cell therapies are transforming precision medicine by enabling real-time, context-responsive interventions that act upon disease-specific cues. Inspired by the success of CAR-T cells in oncology, next-generation platforms are being developed using diverse immune cells and stem cells to address a broader spectrum of diseases. These living therapeutics harness synthetic gene circuits to induce targeted cytotoxicity, to modulate the secretion of effector proteins or to coordinate both functions in response to endogenous signals or externally delivered molecular and physical triggers. Ex vivo engineering of autologous cells remains the norm, but challenges in scalability, cost and accessibility are fuelling efforts towards allogeneic products and in vivo reprogramming. Advances in targeted delivery — using viral vectors, mRNA-loaded nanoparticles and virus-like particles — are expanding the toolkit for direct programming of cells within the body. This Review discusses emerging strategies for engineering human cells with therapeutic functions, highlighting modular control systems, delivery innovations and the translational hurdles that lie ahead. In this Review, Teixeira et al. discuss emerging strategies for developing and improving engineered-cell therapies. They outline progress from ex vivo engineered autologous cells to in vivo reprogramming, advances in delivery systems and the remaining translational barriers.

Plant diseases pose a great risk to global food security, and recent research indicates that pathogen pressures on plant productivity will substantially increase under ongoing climate change (that is, increasing CO2 levels and global warming). However, our mechanistic and predictive knowledge of the impacts of climate extremes, such as heatwaves and prolonged droughts, and their interaction with other climatic factors, on plant pathogens, hosts and microbiomes, remains largely unknown. This is an important knowledge gap that limits our ability to develop effective strategies to mitigate the socioeconomic impacts of climate change-induced plant disease outbreaks. This Review examines the impacts of key climate extremes on soil-borne pathogens, plant microbiomes and host physiology that ultimately determine disease outcomes. We explore evidence that suggests that the responses of pathogen–host–microbiome interactions to climate extremes may differ in many ways from those to long-term climate change. Climate extremes may increase the virulence and distribution of many pathogens, suppress certain plant immune responses, and weaken the core functions of host microbiomes within the disease triangle, thereby facilitating disease outbreaks. We propose an integrated pathway for harnessing microbiomes to address the critical challenges posed by climate extremes. These insights offer new approaches to mitigate disease risks by harnessing microbiomes and metabolites under climate extremes, with the potential to support climate-resilient and sustainable agricultural and natural ecosystems. In this Review, Singh BK and colleagues discuss the impacts of key climate extremes on soil-borne pathogens, plant microbiomes and host physiology that ultimately determine disease outcomes, as well as the eco-evolutionary mechanisms by which pathogens, hosts and microbiomes may adapt to climate extremes. Finally, they propose an integrated pathway for harnessing microbiomes to address the critical challenges posed by climate extremes.

Artificial intelligence has rapidly entered the field of life sciences, including vaccine development. Here, we introduce ‘reverse vaccinology 3.0’, a transformative approach that could revolutionize the field of vaccinology and contribute to addressing global health challenges. Andreano, McLellan and Rappuoli introduce ‘reverse vaccinology 3.0’, a transformative approach that could revolutionize the field of vaccinology and contribute to addressing global health challenges.

Dermatophilaceae polyphosphate-accumulating organisms (PAOs), formerly classified as Tetrasphaera PAOs, play pivotal roles in enhanced biological phosphorus removal (EBPR). However, their phylogenetic diversity, ecological preferences, and metabolic traits remain poorly characterized, and a robust marker gene for their classification is lacking. Here, we performed an extensive phylogenomic and metabolic analysis of Dermatophilaceae PAOs utilizing 46 newly recovered metagenome-assembled genomes from a laboratory-scale EBPR reactor treating high-strength wastewater and full-scale wastewater treatment plants. These analyses revealed a previously uncharacterized PAO genus, named here as Candidatus Dermatophostum, which shows specific preference for high-phosphorus environments. Its representative species, Ca. Dermatophostum ammonifactor, was enriched in the EBPR reactor and its PAO phenotype was confirmed by polyphosphate staining and fluorescence in situ hybridization. Integrative meta-omics combining genomic, transcriptomic, and protein structure analyses revealed its specialized metabolic capabilities for phosphate metabolism, glycogen synthesis, and dissimilatory nitrate reduction to ammonium. Moreover, Ca. Dermatophostum was found to be widely distributed across wastewater treatment plants worldwide, underscoring both its diverse metabolic capabilities and potential engineering implications for mitigating nitrous oxide (N2O) emissions for EBPR system. Finally, we propose a ppk1-based classification framework that resolves Dermatophilaceae PAOs into six distinct clades, consistent with whole-genome phylogeny, and demonstrates that ppk1 can serve as a reliable marker gene for tracking these populations. Together, these findings expand the ecological and functional understanding of Dermatophilaceae PAOs and highlight their promise for advancing sustainable wastewater treatment and resource recovery.

Proteins exhibit complex phase behavior as they convert between the native state, the liquid condensate (or droplet) state and the solid condensate (or amyloid) state. To facilitate the study of these processes, we describe the FuzDrop method of predicting the condensation propensity of proteins to undergo liquid–liquid phase separation and to subsequently form amyloid aggregates. The method is based on the principle that liquid condensations reflect a balance between enthalpic and entropic contributions; FuzPred is an algorithm that provides sequence-based estimates for these contributions in stoichiometric complexes ( https://fuzpred.bio.unipd.it/predictor ). FuzDrop extends this algorithm to protein condensates, and enables prediction of the propensity for amyloid formation within liquid condensates, known as the condensation pathway to protein aggregation ( https://fuzdrop.bio.unipd.it/predictor ). This prediction is based on the principle that the sequence regions that promote aggregation within liquid condensates have a multiplicity of binding modes, because they have a strong propensity for both entropic-driven interactions to stabilize the droplet state and enthalpic-driven interactions to stabilize the amyloid state. The time required for FuzDrop predictions on the web server scales linearly with protein length and is typically ~30 s for a protein of 500 residues. By enabling predictions of protein phase behavior, FuzDrop may facilitate experimental studies directed at the development of therapies for protein condensation diseases. FuzDrop predicts the condensation propensity of proteins on the basis of their amino acid sequences. This protocol describes the underlying theory and how to use the results to understand liquid-liquid phase separation and amyloid aggregate formation.

Bacteria harness diverse defence systems that protect against phage predation, many of which are encoded on horizontally transmitted mobile genetic elements. In turn, phages evolve counter-defences, driving a dynamic arms race that remains underexplored in human disease contexts. For the diarrhoeal pathogen Vibrio cholerae, a higher burden of its lytic phage ICP1 in patient stool correlates with reduced disease severity. However, direct molecular evidence of lytic phages driving selection of epidemic V. cholerae has not been demonstrated. Here, through clinical surveillance in cholera-endemic Bangladesh, we capture the acquisition of a parasitic antiphage mobile genetic element, PLE11, that initiated a selective sweep coinciding with the largest cholera outbreak in recent records. PLE11 showed potent anti-phage activity against cocirculating ICP1, explaining its rapid and dominating emergence. We identify PLE11-encoded Rta as the defence responsible and provide evidence that Rta restricts phage tail assembly. Using experimental evolution, we predict phage counteradaptations against PLE11 and document the eventual emergence and selection of clinical ICP1 that achieve a convergent evolutionary outcome. Finally, we discover how PLEs balance their dependence on ICP1 tail proteins for horizontal transmission with the restriction of phage tail assembly by Rta: PLEs construct chimeric tails composed of both mobile genetic element-encoded and phage-encoded proteins to ensure their transmission. Collectively, our findings reveal the molecular basis of the natural selection of a globally important pathogen and its virus in a clinically relevant context. The acquisition of a parasitic anti-phage mobile genetic element, PLE11, showing potent anti-phage activity against cocirculating ICP1, and the subsequent evolution of ICP1 to escape this defense, are captured, revealing the molecular basis of the natural selection of a globally notable pathogen and its virus.

Microbial serine proteases are valuable for industrial applications due to broad substrate specificity and stability. However, heterologous overexpression in microbial hosts is often limited by cytotoxicity and poor secretion. This study developed an integrated strategy combining protein engineering and signal peptide optimization to enhance extracellular production of PrtA—a key acid-stable alkaline serine protease—in Komagataella phaffii.  Directed evolution generated the Q245K variant, showing 1.35-fold higher extracellular expression than wild-type PrtA. A machine learning model, MPEPE (Mutation Predictor for Enhanced Protein Expression), was used to identify critical residues involved in protein secretion; saturation mutagenesis at the top-predicted site generated the I342D mutant with 1.48-fold improved productivity. The double mutant PrtA-Q245K/I342D achieved synergistic enhancement (1.84-fold higher secretion) without altering enzymatic properties. Evaluation of nine signal peptides revealed that serum albumin, α-factor (without pro-region), and PrtA’s native signal peptides each doubled the combinatorial mutant’s secretion, yielding 4.98-fold higher expression than the wild-type. In contrast, α-factor pro-region inclusion drastically reduced yields. In a 15-L fed-batch bioreactor, the optimized strain produced PrtA-Q245K/I342D at 4807.5 U/mL, equivalent to 1.5 g/L protein.  The combined approach of directed evolution, machine learning-guided mutagenesis, and signal peptide engineering significantly boosted PrtA secretion while maintaining functional integrity. This strategy demonstrates strong potential for scalable industrial production of challenging heterologous proteases.